Yes, in 2026, Health Canada has so far approved two generic semaglutide products for the treatment of type 2 diabetes
Summary : B12 is available in a variety of forms including oral supplements, sublingual tablets, injectable shots and gel formulas
Comparison of inorganic and organic selenium sources for broilers
Ozempic works with the bodys own ability to lower blood sugar and, as a result, can help lower a persons A1c
An important regulatory note: On December 22, 2025, the FDA approved Novo Nordisk's Wegovy tablet (oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist for chronic weight management, with a national launch in January 2026
Distinct histopathological features of hashimotos thyroiditis with respect to IgG4-related disease